Eunike Christiane Hartanto
Universitas Airlangga

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Tingkat Pengetahuan dan Sikap Mahasiswi tentang Tablet Tambah Darah dalam Upaya Pencegahan Anemia Annisa Mutiara Nandasari Hartono; Dhela Martina Salsabila; Ani Zukhruf Amalia; Emy Siauwono; Angkasa Megistra Ulvan; Gladyza Nanda Mega Silvana; Amanda Fikriyatul Fadhilah; Eunike Christiane Hartanto; Liza Pristianty; Carolyn Wijaya Salim
Jurnal Farmasi Komunitas Vol. 10 No. 1 (2023): JURNAL FARMASI KOMUNITAS
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/jfk.v10i1.41925

Abstract

Remaja putri rentan terhadap defisiensi zat besi. Hal ini karena menstruasi yang dialami remaja putri memungkinkan banyaknya kehilangan darah, sehingga kebutuhan gizi, termasuk zat besi akan bertambah seiring dengan menstruasi. Dalam mengatasi potensi anemia, salah satu suplemen yang digunakan adalah tablet tambah darah. Tablet tambah darah bermanfaat untuk menggantikan kehilangan zat besi akibat menstruasi dan dapat memenuhi kebutuhan zat besi yang tidak dapat dipenuhi dari makanan. Tujuan penelitian ini untuk mengetahui tingkat pengetahuan dan sikap mahasiswi Universitas Airlangga terkait tablet tambah darah. Penelitian ini merupakan penelitian deskriptif observasional dengan menggunakan metode kuantitatif dengan desain cross sectional. Teknik pengambilan sampel yang digunakan adalah non random sampling. Responden dalam penelitian adalah mahasiswi aktif jenjang S1 Universitas Airlangga di Kota Surabaya, berusia 17-23 tahun. Penelitian ini diikuti oleh 103 responden. Hasil penelitian menunjukkan bahwa 4,8% responden mempunyai tingkat pengetahuan rendah, 54,4% mempunyai tingkat pengetahuan sedang, dan 40,8% mempunyai tingkat pengetahuan tinggi. Selain itu, sebagian besar responden yaitu sebesar 94,2% memiliki sikap yang positif, sedangkan 5,8% memiliki sikap negatif terkait tablet tambah darah. Pengetahuan mahasiswi masih perlu ditingkatkan, agar sikap dan kesadaran terkait tablet tambah semakin baik.
Drug Utilization of Statin Therapy in Patients with Acute Coronary Syndrome at the Cardiology and Cardiovascular Outpatient Clinic of Airlangga University Hospital Eunike Christiane Hartanto; Deny Wilson Amanda Sitorus; Wenny Putri Nilamsari; Budi Susetyo Pikir; Marcha Debby Saraswati
Indonesian Health Journal Vol. 5 No. 3 (2026): Indonesian Health Journal
Publisher : Riviera Publishing

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58344/ihj.v5i3.921

Abstract

Acute coronary syndrome (ACS) remains a major cause of cardiovascular morbidity and mortality, and intensive low-density lipoprotein cholesterol (LDL-C) reduction with high-intensity statin therapy is essential for secondary prevention. This study aimed to evaluate statin utilization, treatment appropriateness, drug-related problems, and LDL-C target attainment among patients with ACS. A retrospective observational study was conducted at the Cardiology and Cardiovascular Outpatient Clinic of Universitas Airlangga Hospital, Surabaya, Indonesia. Medical records of patients treated from July to December 2023 were reviewed, and 51 eligible patients receiving statin therapy were included using total sampling. Data were analyzed descriptively. Moderate-intensity statins predominated; simvastatin 20 mg was the most frequently prescribed statin during the first month, whereas atorvastatin 20 mg predominated during the second month, while atorvastatin 40 mg use remained limited. Inappropriate statin therapy was identified in 45 patients (88.24%), including inadequate statin intensity and insufficient treatment duration. Only two patients (3.9%) achieved the recommended LDL-C target of ?55 mg/dL, both after receiving atorvastatin 40 mg. Suspected statin-associated muscle symptoms occurred in four patients (7.84%), while several potential drug–drug interactions were documented. These findings demonstrated that statin therapy for secondary prevention remained suboptimal, highlighting the need for guideline-concordant prescribing, regular LDL-C monitoring, and systematic management of identified drug-related problems.